Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
Department BSD OBG - Educational Programs About the Department The Department of Obstetrics and Gynecology has 140 clinical providers, providing care at the main hospital in Hyde Park and seven off
-
for Molecular Engineering, founded in 2011. The PME integrates science and engineering to address global challenges from the molecular level up. The PME’s rigorous academic and research programs are made possible
-
to keep the public informed of the University's perspectives, programs, and accomplishments. Work is performed with a moderate level of guidance, and typically includes marketing, press relations, creative
-
research initiatives center on patient outcomes following complex vascular surgery. The section also manages a robust fellowship program aimed at educating and preparing the next generation of vascular
-
work programs and track progress against them. Manage DIL staff including Predoctoral Research Professionals, and Research Associates; recruit and train new DIL staff. Manage high-level relationships
-
Booth is proud to claim: -an unmatched faculty. -degree and open enrollment programs offered on three continents. -a global body of nearly 56,000 accomplished alumni. -strong and growing corporate
-
of highly accomplished faculty, postdocs, graduate students, and undergraduates, all of whom push the boundaries of their respective fields. The Department supports a PhD program in Geophysical Sciences while
-
, professional and social activities on campus, around the world and online. ARD raises $550 Million annually to support faculty and researchers, practitioners and patients, and students and programs across
-
intellectual, professional and social activities on campus, around the world and online. ARD raises $600 Million annually to support faculty and researchers, practitioners and patients, and students and programs
-
on the administration, compliance, financial and other related aspects of various clinical studies. The position will support and expand the University of Chicago’s Amyloidosis Program through the volume of clinical